FHRX First Horizon Pharmaceutical (MM)

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX) today announced that it has been added to Standard and Poor's SmallCap 600 Global Industry Classification Standard (GICS(R)) Pharmaceuticals Sub-Industry Index. The Global Industry Classification Standard was jointly launched in 1999 by Standard & Poor's and Morgan Stanley Capital International, two leading providers of global indices. The GICS was developed in response to the global financial community's need for one complete, consistent set of global sector and industry definitions that reflects today's economy and is flexible enough to change as the investment world changes. The Standard and Poor's SmallCap 600 Index is made up of 600 domestic stocks chosen for market size, liquidity, and industry group representation. First Horizon is a specialty pharmaceutical company that markets, develops and sells brand name prescription products for the primary service of cardiology and women's health. First Horizon has a portfolio that includes 15 branded products, of which eight are actively promoted to high prescribing physicians through its nationwide sales force of approximately 525 representatives. First Horizon's website address is www.fhrx.com, but information contained therein is not part of this press release.